Prof. Dr. Ahmed Sahib Abdul-Amir

7.Fulbright grantee for scholars to Kent State University, Ohio, USA in 2012 and alumnus member in the state and Fulbright alumni network.

8.M.B.Ch.B (Bachelor) degree in general Medicine and Surgery, College of Medicine, Alnahrain University, Iraq 1997.

9.French scholarship in Institute de Pasteur and in Institut Nationale dela Sante et Recherche Medicale (INSERM), Tours, France for advanced training in bacteriology and bacterial molecular biology in 2005.

10.Ranked first on PhD graduates in 2006.

11. Two Post-doctorate projects/ certificates conducted for 4 years in University Putra Malaysia, in Kuala Lumpur, Malaysia in the field of Microbiology: novel bacteriophage designing, phage-based therapy, and novel phage-based rapid diagnostic assays. (Please see details below)

12. More than ten years of experience in scientific research and in university teaching (lecturing) in the field of Medical microbiology & biotechnology: 6 years in Iraq and 5 years in Malaysia.

13. Thorough research experience (with two UK-filed PCT international patents) in unique and highly demanded field of recent and futuristic applications of bacteriophages in health including alternative antimicrobials research, novel bacteriophage designing, production of phage lysins, phage- and phage lysin- based biocontrol and bioprocessing, phage and phage lysin therapy, phage-based rapid diagnostic assays which altogether constitute an essential experience in the endeavor for finding functional alternatives for current antimicrobials of human and animal pathogenic microbes. (Please see details and web links below).

14. Winning twice the funding competition held by a leading research funding organization in the Middle East region, namely Arab Science and Technology Foundation (ASTF). Two projects were funded by ASTF, each project lasted 2 years. These projects led to breakthrough and patented outcomes. The lump sum of funding is about 540,000 USD.
15.Three projects were funded by University Putra Malaysia and led to three patents registered at Malaysian IPO (myIPO). The lump sum of funding is approximately 250,000 USD.

16.Supervised one PhD and two master students in the field of Microbiology in University Putra Malaysia.

17. More than 67 refereed scientific articles were published in reputable international journals in the field of Microbiology and Biotechnology for the last 5 years. In addition, 10 conference papers are published in proceedings. (Please see below for details)

18. Twenty two articles published included my name as the first author and 35 articles included my name within the first 3 authors.

19. Three original research papers were addressed as “highly accessed” by a leading medical journals publisher in the United Kingdom, Biomedcentral, UK. http://www.biomedcentral.com/1471-2172/9/73 And http://www.biomedcentral.com/1471-2407/9/403 And http://www.jeccr.com/content/30/1/11

20.Three scientific chapter books were published in 2012 via Intech press, a European publishing house. (Please see below for details)

21.Citation indices: H index= 7 (by Scopus and Thompson Reuter) covering only the published articles from 2008-present. Number of citations by Scopus is 130 (2008-present) and by Thompson Reuter is 61 (2008-present).

22.Two granted UK-filed PCT international patents (WO2010064044 and WO2011098820). The first patent describes the discovery of novel and unprecedented approach for experimental designing of bacteriophages into highly lytic and specific antibacterial agents against any target bacteria (alternatives for antibiotics). The second patent describes a newly invented phage-based rapid diagnostic test by using designed bacteriophages in Limulus Amoebocyte Lysate- based rapid diagnostic assays for pathogenic bacteria. Dr. Ahmed S. Abdulamir is the essential inventor and the one who personally conducted the research in labs. http://www.wipo.int/patentscope/search/en/WO2010064044 And http://www.wipo.int/patentscope/search/en/detail.jsf?docId=WO2011098820&recNum=203&docAn=GB2011050249&queryString=(FP/assay)%20&maxRec=7348

23. One granted UK-filed PCT international patent (WO2011104565) describing the discovery of novel approaches and protocols for formulating specific anti-cancer camelid immunoglobulin against leukemia cancerous cells by using, for the first time, the acid elution method for preparing the tumor associated antigens devoid of major histocompatibility complex antigens which is found to overcome the MHC-restricted species barrier for using camelid antibodies in targeting human molecules. http://www.sumobrain.com/patents/wipo/Camelid-antibodies-use-in-compositions/WO2011104565.html

24.Three Malaysian patents, filed at Malaysian IPO (myIPO): PI2011001615, PI2011001616 and PI2011001617 describing the novel medical, biological and molecular research conducted for discovering and using, for the first time in the world, certain natural products components, from Vigna radiate L. and Brassica oleracea L., as novel anticancer, antiviral and antimicrobial agents. http://www.rmc.upm.edu.my/upmip/index.php?content=getfaculty&ipid=684&ipdetailid=672&projectlead=151&cluster=3&fac=8
25.All six patents, mentioned above, are considered for commercialization by different scientific companies and organizations, including Accuvis Company., ABC Company, and University Putra Malaysia research management center. (Please see below for details).

26.Out of hundreds of elite academic applicants, Dr. Ahmed S. Abdulamir was nominated by Fulbright organization for the Fulbright visiting scholar program- year 2012 for 3 months at Kent state University, Kent, OH, USA. This program aims at enhancing the faculty building capacity along with intensive training on up to date and state-of-art approaches, means, and techniques of university teaching and researching.

27.Member of American Society of Microbiology.

28.Member of Arab Biotechnology Network (ABN) http://biotech.astf.net/index.php?option=com_content&view=article&id=14&Itemid=5

29.Permanent editor in four international biomedical journals.

30.Regular reviewer for several international journals. (Please see below for details).

31.Life-time member in USA State Department alumni and Fulbright alumni.

32.Invited lecturer in special research-oriented topics including “the use of statistics if biomedical research”, “How to use MS Excel in statistics”, and “how to publish in high impact factor journals”. These special topics seminars were Invited lecturer in special research-oriented topics including “the use of statistics if biomedical research”, “How to use MS Excel in statistics”, and “how to publish in high impact factor journals”. These special topics seminars were conducted in University Putra Malaysia in 2010 and 2011.
33.Awards:
A.Gold medal of Scientific research in Malaysia.
B.Award as a listee in Marquis who is who world edition 2011.
C.Award for the best oral and poster presentation in 30th Symposium of Malaysian Society for Microbiology.
D.Winner of the best national creative scientific research in Iraq in 2012.
E.Ranked first on PhD students in 2006.
F.Winner of the Iraqi national prize for distinguished academics for publishing in reputable international medical journals in 2012. (details and web links are below).
G.Winner for Fulbright award for scholars to Kent State University, Ohio, USA in 2012. Got intensive training in 9 academic and research workshops.

34. Active participation (oral and poster presentations) in 10 international conferences in the different fields of Microbiology with 10 conference papers published in the proceedings. (Please see below for details).

Member in the Advisory Council of Health, Science and Environment belonging to the USA Embassy in Baghdad

1.Two Post-doctorate certificates conducted for 4 years in University Putra Malaysia, in Kuala Lumpur, Malaysia in the field of Microbiology: novel bacteriophage designing, phage-based therapy, and novel phage-based rapid diagnostic assays. (Please see details below).
2.Doctoral Degree (PhD in Medical Microbiology, 2006), Joint research of the PhD project between Microbiology Dept., College of Medicine, Alnahrain University and Francois Rebelais University, Tours, France.
3.MD, Iraqi Board of Pathology/Microbiology
4.M.Sc. Medical Microbiology 2001
5.M.B.Ch.,B in General Medicine and Surgery..

- Course specialization: Medical Microbiology
- Fine specializations: Virology & bacteriophage biology/applications, Molecular biology, and Immunology.

Courses and lectures taught to postgraduate biomedical students:
1- Bacterial genetics.
2- Molecular biology applications in bacteriology.
3- Genetics of Virology.
4- Molecular biology applications in virology.
5- Genetics in Immunology and gene therapy
6- Molecular biology applications in Immunology
Practical laboratory courses taught to undergraduate and postgraduate students
1- Basic safety precautions in Molecular Biology laboratories.
2- Extraction techniques of DNA.
3- PCR.
4- RAPD PCR.
5- Gel electrophoresis of DNA.
6- In situ hybridization assay.

Supervise 4 master students in Phage therapy, phage biocontrol, role of EBV in renal transplants rejection.

AREAS OF RESEARCH
- Bacteriophage biotechnology & modern phage applications
- Immune surveillance for viral tumors.
- Bacterially associated carcinogenesis.
- Biotechnology techniques and assays.
- Rapid diagnostic kit development (via bacteriophage and phage lysins).
- Phage design.
- Phage-based diagnostics, biocontrol, and bioprocessing projects.
- Food Microbiology

1. Razieh Amini, Abdulamir AS, Nurul Azreen Mustaffa, Fatemeh Jahanshiri, Beh Poay Ling, Ali Hematian, Morvat Taheri-Kalani, Yasaman Amini, Iraj Pakzad, Zamberi Sekawi and Farid Azizi Jalilian. 2013. Isolation and Identification of Methicillin-resistance Staphylococcus aureus (MRSA) from Nasal of College Students. 7(4): 3155-62.

2. R.R. Hafidh, A.S. Abdulamir, F. Abu Bakar, F.A. Jalilian, F. Jahanshiri, F. Abas, Z. Sekawi. (2013). Novel anticancer activity and anticancer mechanisms of Brassica oleracea L. var. capitata f. rubra. European J of Integrative Medicine. Prepublication Online.

3. Amini, R, Jalilian, FA, Abdullah, S, Veerakumarasivam, A, Hosseinkhani, H, Abdulamir, AS, Domb, AJ, Ickowicz, D, Rosli, R. (2013). Dynamics of PEGylated-Dextran-Spermine Nanoparticles for Gene Delivery to Leukemic Cells. APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY, 170(4): 841-853.

4. Abdulamir AS. 2013. An Overview on the Current and Futuristic Rapid Diagnostic Assays. Irq. J Med. Sci. 11(1): 1-3.

5. Abdulamir AS, Hafidh RR, Fatimah Abu Bakar. 2013. The tumoricidal activity of Salmonella and its role in treating cancers. Cancer Therapy. 8(2): 10-23 http://cancer-therapy.org/CT/v9/A/2.Abdulamir_et_al%20_10-23.pdf

7. Razia Amini, Farid Azizi Jalilian, Ahmed S. Abdulamir, Ayaud Veerakumarasivam, S Nadali, and Rozita Rosli. 2013. Soluble Flt-1 gene delivery in acute myeloid leukemic cells mediating a non-viral gene carrier. Biomed Research International. Article in press (online). http://www.hindawi.com/journals/biomed/aip/752603/

8. Behnaz Hassanbaglou, Azizah Abdul Hamid1,* A. M. Roheeyati, Norihan Mohd Saleh, Ahmad Sahib Abdulamir, Alfi Khatib and Sabu M. 2012. C4Antioxidant activity of different extracts from leaves of Pereskia bleo (Cactaceae). Journal of Medicinal Plants Research, 6(15): 2932-2937.


9. Razieh Amini, Abdulamir AS , Cheng Chung, Fatemeh Jahanshiri, Chyn Boon Wong, Beh Poyling, Ali Hematian, Zamberi Sekawi, Mohsen Zargar, Farid Azizi Jalilian. 2012. Circulation and transmission of methicillin-resistant Staphylococcus aureus among college students in Malaysia (cell phones as reservoir). Asian Biomedicine. 6(5): 659-673.

10. Razieh Amini, Abdulamir AS, Fatemeh Jahanshiri, Lee Chye Shan, Ali hematian, Yasaman Amini, Zamberi Sekawi and Farid Azizi Jalilian. 2012. Isolation and identification of methicillin-resistant Staphylococcus aureus from students’ coins. African Journal of Biotechnology 11(50):11143-11149.

11. R. Amini, H. Hosseinkhani , Abdulamir AS, R.Rosli, F. Azizi Jalilian. 2012. Engineered Smart Biomaterials for Gene Delivery. Gene Therapy and Molecular Biology. 14: 72-86.

12. Rand R Hafidh, Ahmed S Abdulamir, Fatimah Abu Bakar, Farid Azizi Jalilian, Faridah Abas, Zamberi Sekawi. 2012. Novel molecular, cytotoxical, and immunological study on promising and selective anticancer activity of Mung bean sprouts. BMC Complementary and Alternative Medicine. 12:208.

13. Hafidh RR, Abdulamir AS, AbuBakar F. 2012. Phenotype microarray profiling of the antibacterial activity of red cabbage. Functional food in health and disease. 2(6): 212-227.

14. Razieh Amini, A. S. Abdulamir, Beh Poay Ling, Fatemeh Jahanshiri, Ali Hematian, Mohsen Zargar, Zamberi Sekawi and Farid Azizi Jalilian. 2012. Isolation and Identification of Methicillin-Resistant taphylococcus aureus from Keys of College Students Using Different Detection Methods. British Biotechnology Journal. 2(1):13-25.

15. Abdulamir AS. Molecular assessment of Staphyloccoal bacteria in highly educated communitites. 2012. Irq. Med. J. [prepublication version].

16. Jassim SAA, Abdulamir AS, Abu Bakar F. 2012. Novel phage-based bioprocessing of pathogenic Escherichia coli and its biofilms. World Journal of Microbiology and Biotechnology. 28 (1): 47-60.

17. Mohammad Raftari, Farid Azizi Jalilian, Ahmed Sahib Abdulamir, Sobhan Ghafurian, Zamberi Sekawi, Radu Son and Fatimah Abu Bakar. 2012. Antibacterial activity of organic acids on Salmonella and Listeria. ASIA LIFE SCIENCEs. 21:1.

18. Raftari, M., Azizi Jalilian F., Abdulamir, A. S., Sobhan Ghafurian, Radu S.,Sekawi Z. and Abu Bakar F. 2011. Optimized antibacterial measures against Escherichia coli O157:H7 and Staphylococcus aureus. African Journal of Microbiology Research. 5(20): 3113-3121.

19. Rand R. Hafidh, Abdulamir AS, Law Se Vern, Fatimah Abu Bakar, Faridah Abas, Fatemeh Jahanshiri and Zamberi Sekawi. 2011. Novel in vitro antimicrobial activity of Vigna radiata (L.) R. Wilczek against highly resistant bacterial, and fungal pathogens. Journal of Medicinal Plants Research. 5(16): 3606-3618.

20. Abdulamir AS. 2011. The association among diet, prebiotic and probiotic. Irq JMS. 9 (4): 292-294.

21. Willy PW, Abdel Ameer AS, Fatimah Abu Bakar, Nazamid B Saari, Zamberi Sekawi, Hanis Hazeera. 2011. Amino acids and biogenic amines determination in Mystus Nemurus. Journal of Food Processing and Preservation. 35 (3): 342-348.

22. Hafidh RR, Abdulamir AS, Abubakar F. 2011. Inhibition of Growth of Highly Resistant Bacterial and Fungal Pathogens by a Natural Product. The Open Microbiology Journal, 2011, 5:96-106.

23. Abdulamir AS, Hafidh RR, Abu Bakar F. 2011. The association of Streptococcus bovis/gallolyticus with colorectal tumors: The nature and the underlying mechanisms of its etiological role. J Exp Clin Cancer Res. 30:11.

24. Abdulamir, A.S., Hafidh, R.R., Bakar, F.A., 2010. Molecular detection, quantification, and isolation of Streptococcus gallolyticus bacteria colonizing colorectal tumors: inflammation-driven potential of carcinogenesis via IL-1, COX-2, and IL-8. Mol Cancer. 9: 249.

25. Sadeghifard N, Ranjbar R, Zaeimi J, Alikhani MY, Ghafouryan S, Raftari M, Abdulamir AS, Delpisheh A, Mohebi R, Abu Bakar F. 2010. Antimicrobial susceptibility, plasmid profiles and RAPDPCR typing of Acinetobacter bacteria. Asian Biomedicine. 4: 6.

26. Khoshraftar E, Anvari HM, Assadi HK, Abdulamir AS, Abu baker F. 2010. Comparative study on the effectiveness of acetaminophen and diclofenac pretreatment in the relief of acute pain after out-patient surgery. European Journal of Dentistry and Medicine. 2: 1-6.

27. Rand R. Hafidh, A.S. Abdulamir, Law Se Vern and Fatimah Abu Bakar. 2010. The Inhibition of Human Pathogens: Trichophyton rubrum and Trichoderma harzianum by a Natural Product. American Journal of Biochemistry and Biotechnology 6 (1): 40-46, 2010.

28. Tanaz, Alipour, Nourkhoda, Sadeghifard, Nour, amirmozafari, Sobhan, Ghafurian, Abdulamir,A.S., Reza, Mohebi, Fatimah, Abu Bakar, Mohammad, Raftari. 2010. Incidence of Extended Spectrum Beta-lactamase Producing Pseudomonas Aeruginosa and Frequency of OXA-2 and OXA-10 Genes. AJBAS. 2: 3202-3215.

29. Sadeghifard N, Salari M.H, Ranjbar R, Ghafouryan S, Raftari M, Abdulamir A.S, Fatimah A.B, Kazemi B. 2010. The clinical and environmental spread and diversity of toxigenic Clostridium difficile diarrhea in the region of the Middle East. Reviews in Infection. 1: 180-187.

30. Fadi Fouad Alsamak, Ahmed Sahib Abdulamir, Laila Khalid Mahdi, Khalid Alnaib, Fatimah Abu Bakar. 2010. Association of Helicobacter pylori with colorectal cancer Development. Asian Biomedicine. 4: 609-618.

31. Abdulamir AS, Hafidh, RR, Abubakar F. 2010. In vitro immunogenic and immunostimulatory effects of zwitterionized 23-valent pneumococcal polysaccharide vaccine compared with nonzwitterionized vaccine. Current therapeutic research. 71:60-77.

32. Pakzad I, Rezae A, Rasaee MJ, Hosseini AZ, Tabaraee B, Ghafurian S, Abdulamir AS, Abu Bakar F, Raftari M. 2010. Novel approach of vaccination against Brucella aborus 544 based on a combination of fusion proteins, human serum albumin and Brucella abortus lipopolysaccharides. Journal of biological sciences.

33. Bakar FA, Abdulamir AS, Nordin N, Yoke TS. 2010. Methods for precise molecular detection of probiotic microflora: Using adjusted molecular biology protocols, primer sets and PCR assays. Biotechnology. 9(1):25-32.

34. Abdulamir AS, Yoke TS, Nordin N, Abu Bakar F. 2010. Detection and quantification of probiotic bacteria using optimized DNA extraction, traditional and real-time PCR methods in complex microbial communities. African Journal of Biotechnology. 9(10):1481-92.

35. Salleh AB, Bakar FA, Yusof NA, Abdulamir AS, Heng LY. 2010. Risk and health effect of boric acid. American Journal of Applied Sciences. 7(5):620-7.

36. Suzita R, Abu Bakar F, Son R, Abdulamir AS. 2010. Detection of vibrio cholerae in raw cockles (anadara granosa) by polymerase chain reaction. International Food Research Journal. 17(3):675-80.

37. Huda-Faujan, N., Abdulamir, A.S., Fatimah, A.B., Anas, O.M., Shuhaimi, M., Yazid, A.M., Loong, Y.Y., 2010. The impact of the level of the intestinal short chain Fatty acids in inflammatory bowel disease patients versus healthy subjects. Open Biochem J 4, 53-58.

38. R. Suzita, A.S. Abdulamir, Fatimah Abu Bakar, R. Son. 2009. A Mini Review: Cholera Outbreak via Shellfish. American Journal of Infectious Diseases. 5: 40-47.

39. Suwaibah Ghaffar, Abdulamir AS, Fatimah Abu Bakar, Roselina Karim, Nazamid Saari. 2009. Microbial Growth, Sensory Characteristic and pH as Potential Spoilage Indicators of Chinese Yellow Wet Noodles from Commercial Processing Plants. American Journal of Applied Sciences. 6: 1059-1066.

40. Willy Pranata Widjaja, A.S. Abdulamir, Nazamid B. Saari, Fatimah Bt. Abu Bakar and Zamri B. Ishak. 2009. Fatty Acids Profile of Tropical Bagridae Catfish (Mystus nemurus) During Storage. American Journal of Food Technology. 4: 90-95.

41. Rand R. Hafidh, Faridah Abas, Ahmed S. Abdulamir, Fatemeh Jahanshiri, Fatimah Abu Bakar and Zamberi Sekawi. 2009. A Review: Cancer Research of Natural Products in Asia. International Journal of Cancer Research. 5: 69-82.

42. Willy Pranata Widjaja , A.S. Abdulamir , Fatimah Bt. Abu Bakar , Nazamid B. Saari , Zamri B. Ishak and A. Abdul Hamid. 2009. Lipid Quality Deteroriation of Bagridae Catfish (Mystus nemurus) During Storage. Research Journal of Biological Sciences. 4: 525-530.

43. Muhammad Zukhrufuz Zaman ; A.S. Abdulamir ; Fatimah Abu Bakar ; Jinap Selamat ; Jamilah Bakar. 2009. A Review: Microbiological, Physicochemical and Health Impact of High Level of Biogenic Amines in Fish Sauce. American Journal of Applied Sciences. 6: 1199-1211.

44. Hafidh, RR, Abdulamir, AS, Jahanshiri, F Abas, F Bakar, Sekawi, Z. 2009. Asia is the Mine of Natural Antiviral Products for Public Health. Open Complementary Medicine Journal. 1: 58-68.

45. Abbas KA, Abdulamir AS, Ebrahimian M, Jamilah B. 2009. Thermal properties variation of malaysian yellowtail catfish during precooling process and numerical verification. Journal of Food, Agriculture and Environment. 7(2):196-201.

46. Moghaddam FY, Darvish J, Shahri NM, Abdulamir AS, Mousavi M, Daud SK. 2009. Comparative histological and histochemical inter-species investigation of mammalian sub mandibular salivary glands. Research Journal of Applied Sciences. 4(1):50-6.

47. Moghaddam FY, Darvish J, Shahri NM, Abdulamir AS, Daud SK. 2009. Lectin histochemistry assay in colon tissues for inter-species characterization. American Journal of Biochemistry and Biotechnology. 5(1):7-13.

48. Raftari M, Jalilian FA, Abdulamir AS, Son R, Sakawy Z, Fatimah AB. 2009. Novel approaches of E. coli O157: H7 decontamination. Research Journal of Medical Sciences. 3(4):158-62.

49. Ali FWO, Saari NB, Bakar FA, Abdulamir AS, Mohammed AS, Manap YA, Zulkifli AH. 2009. Novel, practical and cheap source for isolating beneficial γ-aminobutyric acid-producing leuconostoc NC5 bacteria. Research Journal of Medical Sciences. 3(4):146-53.

50. Indang MN, Abdulamir AS, Abu Bakar A, Salleh AB, Lee YH, Nor Azah Y. 2009. A review: Methods of determination of health-endangering formaldehyde in diet. Research Journal of Pharmacology. 3(2):31-47.

51. Norliana S, Abdulamir AS, Abu Bakar F, Salleh AB. 2009. The health risk of formaldehyde to human beings. American Journal of Pharmacology and Toxicology 4(3):98-106.

52. Hafidh RR, Abdulamir AS, Abu Bakar F, Abas F, Jahanshiri F, Sekawi Z. 2009. Antioxidant research in Asia in the period from 2000-2008. American Journal of Pharmacology and Toxicology. 4(3):48-66.

53. Wan Norhasima WM, Abdulamir AS, Abu Bakar F, Son R, Norhafniza A. 2009. The health and toxic adverse effects of fusarium fungal mycotoxin, fumonisins, on human population. American Journal of Infectious Diseases. 5(4):280-8.

54. Raftari M, Azizi Jalilian F, Abdulamir AS, Son R, Sekawi Z, Fatimah AB. 2009. Practical and novel sterilization approach for the pathogenic staphylococcus aureus bacteria. American Journal of Infectious Diseases. 5(4):301-7.

55. Raftari, M., Jalilian, F.A., Abdulamir, A.S., Son, R., Sekawi, Z., Fatimah, A.B., 2009. Effect of Organic Acids on Escherichia coli O157:H7 and Staphylococcus aureus Contaminated Meat. Open Microbiol J 3, 121-127.

56. Abdulamir, A.S., Kadhim, H.S., Hafidh, R.R., Ali, M.A., Faik, I., Abubakar, F., Abbas, K.A., 2009. Severity of asthma: the role of CD25+, CD30+, NF-kappaB, and apoptotic markers. J Investig Allergol Clin Immunol 19, 218-224.

57. Abdulamir, A.S., Hafidh, R.R., Mahdi, L.K., Al-jeboori, T., Abubaker, F., 2009. Investigation into the controversial association of Streptococcus gallolyticus with colorectal cancer and adenoma. BMC Cancer 9, 403.

58. Abdulamir, A.S., Hafidh, R.R., Kadhim, H.S., Abubakar, F., 2009. Tumor markers of bladder cancer: the schistosomal bladder tumors versus non-schistosomal bladder tumors. J Exp Clin Cancer Res 28, 27.

59. Abdulamir, A.S., Hafidh, R.R., Abubakar, F., 2009. Different inflammatory mechanisms in lungs of severe and mild asthma: crosstalk of NF-kappa-B, TGFbeta1, Bax, Bcl-2, IL-4 and IgE. Scand J Clin Lab Invest 69, 487-495.

60. Abdulamir, A.S., Hafidh, R.R., Abu Bakar, F., Abbas, K., 2009. Novel Epstein-Barr virus immunoglobulin G-based approach for the specific detection of nasopharyngeal carcinoma. Am J Otolaryngol.

61. Abdulamir AS, Hafidh RR, Mahdi LK, Al-jeboori TR, Abubaker F, Abbas KA. 2008. The interplay between p53 and p21 tumor suppressor proteins in the transformation of colorectal adenoma to carcinoma. American Journal of Immunology. 4(1):14-22.

62. Abdulamir AS, Hafidh RR, Abdulmuhaimen N, Abubaker F, Abbas KA. 2008. Better understanding of the immunosuppressive link between the lymphocytic immune cells and the decreased cell mediated immunity in head and neck cancer patients. American Journal of Immunology. 4(3):26-32.

63. Abbas KA, Mohamed A, Abdulamir AS, Abas HA. 2008. A review on supercritical fluid extraction as new analytical method. American Journal of Biochemistry and Biotechnology. 4(4):345-53.

64. Hafidh, R.R., Abdulamir, A.S., 2008. Cladosporium spp. as a causative agent of white superficial onychomycosis. East Mediterr Health J 14, 231-233.

65. Abdulamir, A.S., Hafidh, R.R., Abubakar, F., Abbas, K.A., 2008. Changing survival, memory cell compartment, and T-helper balance of lymphocytes between severe and mild asthma. BMC Immunol 9, 73.

66. Abdulamir, A.S., Hafidh, R.R., Abdulmuhaimen, N., Abubakar, F., Abbas, K.A., 2008. The distinctive profile of risk factors of nasopharyngeal carcinoma in comparison with other head and neck cancer types. BMC Public Health 8, 400.

67. Kadhim HS, Abdulamir AS, Hafidh RR, Abubakar F, Abbas, K. 2008. Investigations in the molecular events of Transitional Cell Carcinoma of the Bladder. Am J Bioch Biotech. 4 (4): 408-415.

68. Abdulamir AS, Nidhal Abdulmuhaimen. 2006. Evaluation of EBV serum and salivary IgA antibodies in head and neck cancer patients. Iraqi Postgraduate Medical Journal. 5(2): 209-212.

69. Abdulamir AS, Nidhal Abdulmuhaimen. 2002. Microculture tetrazolium assay MTT application for measuring cell-mediated immunity CMI and evaluating certain mitogenic substances as future drugs of immune therapy for Head and neck cancer patients. Essential Medical Sciences Journal, 1(1): 102-105.

70. Abdulamir AS, Nidhal Abdulmuhaimen. 2002. Anti-EBV serum immunoglobulins A &G are useful serological markers for the early diagnosis of Nasopharyngeal Carcinoma NPC patients and for the screening of population. 2002. Journal of University of Bahrain. 12(3): 65-69.
Note: Up to 2013, 8 papers are under processing for publication in biomedical journals.


R E F E R E E D C H A P T E R B O O K S
My professional profile in Intech Press for scientific books: http://www.intechopen.com/profiles/78680/ahmed-abdulamir

71. Abdulamir, A.S., Muhammad Zukhruf Zaman,Hafidh R.R., Abu Bakar F. 2012. The Role of Diet, Prebiotic and Probiotic in the Development and Management of Inflammatory Bowel Diseases (IBD). In: INFLAMMATORY BOWEL DISEASE – ADVANCES IN PATHOGENESIS AND MANAGEMENT. Karoubi S. (eds.), Intech Press, Croatia, pp. 249-274. ISBN: 978-953-307-891-5 http://www.intechopen.com/books/inflammatory-bowel-disease-advances-in-pathogenesis-and-management

72. Abdulamir, A.S., Hafidh, R.R., Abubaker, F. 2012. The Novel Use of Zwitterionic Bacterial Components and Polysaccharides in Immunotherapy of Cancer and Immunosuppressed Cancer Patients. In: ADVANCEMENTS IN TUMOR IMMUNOTHERAPY AND CANCER VACCINES. Arnouk H. (eds.), Intech Press, Croatia, pp. 155-174. ISBN: 978-953-307-998-1 http://www.intechopen.com/books/advancements-in-tumor-immunotherapy-and-cancer-vaccines/the-novel-use-of-zwitterionic-bacterial-components-and-polysaccharides-in-immunotherapy-of-cancer-an

73. Abdulamir, A.S., Hafidh, R.R., Abubaker, F. 2012. Streptococcus bovis/gallolyticus Induce the Development of Colorectal Cancer. In: COLORECTAL CANCER BIOLOGY –FROM GENES TO TUMOR. Ettarh R. (Eds.). Intech Press, Croatia, pp.375-390. ISBN: 978-953-51-0062-1 http://www.intechopen.com/books/colorectal-cancer-biology-from-genes-to-tumor/streptococcus-bovis-gallolyticus-induce-the-development-of-colorectal-cancer

P A T E N T S (2008-present)

Granted international patents

1. METHODS FOR BACTERIOPHAGE DESIGN

Patent no. WO2010064044, UK Application No. 0822068.3. Filing date: 3rd December 2008, International Application No. PCT/GB2009/051641. Filing date: 3rd December 2009.
http://www.wipo.int/patentscope/search/en/WO2010064044 And

http://www.freepatentsonline.com/EP2367934.html And
http://www.sumobrain.com/patents/wipo/Methods-bacteriophage-design/WO2010064044.html

United Kingdom Patent GB2466177: http://www.directorypatent.com/GB/ GB2466177ZZUCZZA.html

European patent Directory: http://worldwide.espacenet.com/publication Details/biblio?CC=EP&NR=2367934

2. RAPID DETECTION OF BACTERIA

Patent no. WO2011098820, UK Application No. 1002295.2. Filing date: 11th February 2010. International Application No. PCT/GB2011/050249. Filing date: 11th February 2011. http://www.wipo.int/patentscope/search/en/detail.jsf?docId=WO2011098820&recNum=203&maxRec=7348&office=&prevFilter=&sortOption=&queryString=%28FP%2Fassay%29+&tab=PCT+Biblio

And http://www.freepatentsonline.com/WO2011098820.html

United Kingdom Patent GB2477752: http://www.directorypatent.com/GB/ GB247 7752A.html
European Patents Directory: http://worldwide.espacenet.com/publicationDetails/biblio?DB=EPODOC&II=3&ND=3&adjacent=true&locale=en_EP&FT=D&date=20110818&CC=WO&NR=2011098820A1&KC=A1

3. COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER

Patent no. WO2011104565, UK Application No. 1003198.7. Filing date: 25th February 2010. International Application No. PCT/GB2011/050382. Filing date: 25th February 2011.
http://www.wipo.int/patentscope/search/en/detail.jsf?docId=WO2011104565&recNum=78&docAn=GB2011050382&queryString=treg&maxRec=1282

European Patents Directory: http://worldwide.espacenet.com/ publicationDetails/biblio?DB=EPODOC&II=2&ND=3&adjacent=true&locale=en_EP&FT=D&date=20110901&CC=WO&NR=2011104565A1&KC=A1


4. AN ANTIVIRAL COMPOSITION

• Malaysian Patent Application No. PI2011001615.
• Filing date: 12th April 2011.
http://www.rmc.upm.edu.my/upmip/index.php?content=getfaculty&ipid=684&ipdetailid=672&projectlead=151&cluster=3&fac=8


5. AN ANTIMICROBIAL COMPOSITION

• Malaysian Patent Application No. PI2011001616.
• Filing date: 12th April 2011.
http://www.rmc.upm.edu.my/upmip/index.php?content=getfaculty&ipid=685&ipdetailid=673&projectlead=151&cluster=3&fac=8

6. AN ANTICANCER COMPOSITION

• Malaysian Patent Application No. PI2011001617.
• Filing date: 12th April 2011.
http://www.rmc.upm.edu.my/upmip/index.php?content=getfaculty&ipid=683&ipdetailid=671&projectlead=151&cluster=3&fac=8